Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Diabetes, High Blood Pressure May Cause People with Alzheimer’s Disease to Die Sooner

04.11.2008
People with Alzheimer’s disease who also have diabetes or high blood pressure may die sooner than people without such disorders, according to a study published in the November 4, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.

The study involved 323 people who had no memory problems when first tested but later developed dementia. Memory tests and physical exams were then given every 18 months.

The study found that after an Alzheimer’s diagnosis was made, people with diabetes were twice as likely to die sooner than those without diabetes who had Alzheimer’s disease. People with Alzheimer’s disease who had high blood pressure were two-and-a-half times more like to die sooner than those with normal blood pressure.

“Studies show that the average lifespan of a person diagnosed with Alzheimer’s can be anywhere from three to nine years. For that person and their caregiver, every minute counts. Here we have two controllable factors that may drastically affect how long that person can survive,” said study author Yaakov Stern, PhD, professor at the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain and director of the Cognitive Neuroscience Division of Gertrude H. Sergievsky Center at Columbia University Medical Center in New York. Stern is also a member of the American Academy of Neurology.

The study also looked at how race could affect how long a person lives with Alzheimer’s disease. It found Hispanic people lived for eight years after diagnosis, about four years longer than non-Hispanic white people did. African-Americans lived an average of five years, longer than non-Hispanic whites but not as long as Hispanic people. However, after adjusting for gender and other factors, the results were no longer significant.

“Though these findings were not significant, they are intriguing and warrant further research as to whether race affects survival time in people with Alzheimer’s disease,” said Stern.

The study was supported by the National Institute on Aging.

The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington’s disease, and dementia.

Angela Babb | American Academy of Neurology
Further information:
http://www.aan.com

Further reports about: Academy Aging Alzheimer Diabetes Disease Neurology blood flow blood pressure

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Flying: Efficiency thanks to Lightweight Air Nozzles

23.10.2017 | Materials Sciences

Salmonella as a tumour medication

23.10.2017 | Life Sciences

50th Anniversary at JULABO GmbH

23.10.2017 | Press release

VideoLinks
B2B-VideoLinks
More VideoLinks >>>